Glioblastoma multiforme (GBM), a common malignant neurological tumor, has boundaries
indistinguishable from those of normal tissue, making complete surgical removal ineffective …

Conventional therapeutic techniques for brain tumours have limitations and side effects,
necessitating the need for alternative treatment options. MRI-monitored therapeutic hydrogel …

Chemotherapy is commonly associated with limited effectiveness and unwanted side effects
in normal cells and tissues, due to the lack of specificity of therapeutic agents to cancer cells …

The management of brain tumors presents numerous challenges, despite the employment of
multimodal therapies including surgical intervention, radiotherapy, chemotherapy, and …

Among central nervous system tumors, Glioblastoma (GBM) is the most common, aggressive
and neurological destructive primary brain tumor in adults. Standard care therapy for GBM …

Glioma is considered the primary brain tumor to cause brain illnesses, and it is difficult to
treat and shows resistance to various routine therapeutics. The most common treatments to …

Glioblastoma multiforme (GBM) tumors, which arise from glia in the central nervous system
(CNS), are one of the most deadly forms of human cancer with a median survival time of∼ 1 …

Patients diagnosed with glioma typically face a limited life expectancy (around 15 months on
average), a bleak prognosis, and a high likelihood of recurrence. As such, glioma is …

Glioblastoma multiforme (GBM) is an aggressive primary brain cancer and although patients
undergo surgery and chemoradiotherapy, residual cancer cells still migrate to healthy brain …

Brain tumors exhibit vast genotypic and phenotypic diversity depending on patient age and
anatomical location. Hydrogels hold great promise as 3D in vitro models for studying brain …